When you buy shares in a company, there is always a risk that the price drops to zero. But when you pick a company that is really flourishing, you can make more than 100%. Take, for example Orthocell ...

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has reported that its Remplir™ nerve repair device has been used in 23 surgical procedures on Ukrainian soldiers injured in combat, marking an important real-world ...

Johnson & Johnson’s DePuy Synthes Products is collaborating with Orthocell on development of a stem cell-based approach to the regeneration of tendons. The partners are due to start a clinical trial ...

Orthocell receives approval for Remplir™ to be used across the United States Department of Defence (DoD) and Veterans Affairs (VA) hospital networks, comprising: For context, Orthocell has already ...

Orthocell Ltd (AU:OCC) has released an update. Orthocell Ltd has announced the issuance of 28,166,664 ordinary fully paid securities, which will be listed on the Australian Securities Exchange (ASX).

Regenerative medicine company Orthocell Limited is pleased to announce positive 3-5 year data from a study of its tendon cell treatment for tennis elbow has been presented at the International ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Orthocell Ltd is gearing up for a ...

Orthocell eyes US nerve repair market Less than 1% market share could reach breakeven Remplir begins early US sales momentum In operating theatres across the United States, surgeons repair hundreds of ...

Management “couldn’t be happier” with the early US rollout of its flagship device, Remplir Revenue should start slowly but then escalate rapidly in ‘hockey stick’ style Following Remplir’s surprise ...

These injuries come from everything from car accidents and workplace trauma to complex reconstructive surgery. And while the science of nerve repair has advanced enormously in the past few decades, ...

Orthocell receives approval for Remplir™ to be used across the United States Department of Defence (DoD) and Veterans Affairs (VA) hospital networks, comprising: 51 DoD military hospitals; and 170 ...